These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9527100)

  • 1. Levels of soluble Fas in patients with myocarditis, heart failure of unknown origin, and in healthy volunteers.
    Toyozaki T; Hiroe M; Saito T; Iijima Y; Takano H; Hiroshima K; Kohno H; Ishiyama S; Marumo F; Masuda Y; Ohwada H
    Am J Cardiol; 1998 Mar; 81(6):798-800. PubMed ID: 9527100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of soluble form of Fas molecule in patients with congestive heart failure.
    Okuyama M; Yamaguchi S; Nozaki N; Yamaoka M; Shirakabe M; Tomoike H
    Am J Cardiol; 1997 Jun; 79(12):1698-701. PubMed ID: 9202370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of disease course in patients with acute myocarditis.
    Fuse K; Kodama M; Okura Y; Ito M; Hirono S; Kato K; Hanawa H; Aizawa Y
    Circulation; 2000 Dec; 102(23):2829-35. PubMed ID: 11104740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of soluble Fas/APO-1 receptor in human retroviral infection and associated diseases.
    Kamihira S; Yamada Y; Hiragata Y; Yamaguchi T; Izumikawa K; Matsuo Y; Sugahara K; Tsuruta K; Atogami S; Tsukasaki K; Maeda T; Tomonaga M
    Intern Med; 1997 Mar; 36(3):166-70. PubMed ID: 9144006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble antiapoptotic molecules and immune activation in chronic heart failure and unstable angina pectoris.
    Fiorina P; Astorri E; Albertini R; Secchi A; Mello A; Lanfredini M; Craveri A; Olivetti G; Quaini F
    J Clin Immunol; 2000 Mar; 20(2):101-6. PubMed ID: 10821461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane and soluble forms of Fas (CD95) and Fas ligand in peripheral blood mononuclear cells and in plasma from human immunodeficiency virus-infected persons.
    Hosaka N; Oyaizu N; Kaplan MH; Yagita H; Pahwa S
    J Infect Dis; 1998 Oct; 178(4):1030-9. PubMed ID: 9806031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma soluble fas and soluble fas ligand in chronic glomerulonephritis.
    Sano H; Asano K; Minatoguchi S; Hiraoka J; Fujisawa K; Nishigaki K; Yasuda N; Kumada H; Takemura M; Ohashi H; Seishima M; Fujiwara T; Fujiwara H
    Nephron; 1998 Oct; 80(2):153-61. PubMed ID: 9736812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do elevated levels of serum-soluble fas contribute to the persistence of activated lymphocytes in systemic lupus erythematosus?
    Bijl M; van Lopik T; Limburg PC; Spronk PE; Jaegers SM; Aarden LA; Smeenk RJ; Kallenberg GG
    J Autoimmun; 1998 Oct; 11(5):457-63. PubMed ID: 9802929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proinflammatory cytokines, soluble Fas receptor, nitric oxide and angiotensin converting enzyme in congestive heart failure.
    El Sherif WT; El Tooney LF; Meki AR; Abdel Moneim A
    Egypt J Immunol; 2005; 12(1):39-48. PubMed ID: 16734138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Soluble-Fas, Inflammation, and Anemia in Acute Kidney Injury.
    Góes MA; Iizuka IJ; Quinto BM; Dalboni MA; Monte JC; Santos BC; Dos Santos OFP; Pereira VG; Durão MS; Batista MC; Cendoroglo M
    Artif Organs; 2018 Sep; 42(9):E283-E289. PubMed ID: 23566289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated soluble Fas/APO-1 (CD95) levels in silicosis patients without clinical symptoms of autoimmune diseases or malignant tumours.
    Tomokuni A; Aikoh T; Matsuki T; Isozaki Y; Otsuki T; Kita S; Ueki H; Kusaka M; Kishimoto T; Ueki A
    Clin Exp Immunol; 1997 Nov; 110(2):303-9. PubMed ID: 9367417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated serum levels of soluble Fas/APO-1 (CD95) in patients with hepatocellular carcinoma.
    Jodo S; Kobayashi S; Nakajima Y; Matsunaga T; Nakayama N; Ogura N; Kayagaki N; Okumura K; Koike T
    Clin Exp Immunol; 1998 May; 112(2):166-71. PubMed ID: 9649177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levels of soluble Fas ligand in myocarditis.
    Toyozaki T; Hiroe M; Tanaka M; Nagata S; Ohwada H; Marumo F
    Am J Cardiol; 1998 Jul; 82(2):246-8. PubMed ID: 9678301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum concentration of sFas and sFasL in healthy HBsAg carriers, chronic viral hepatitis B and C patients.
    Lapinski TW; Kowalczuk O; Prokopowicz D; Chyczewski L
    World J Gastroenterol; 2004 Dec; 10(24):3650-3. PubMed ID: 15534924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between plasma levels of cardiac natriuretic peptides and soluble Fas: plasma soluble Fas as a prognostic predictor in patients with congestive heart failure.
    Tsutamoto T; Wada A; Maeda K; Mabuchi N; Hayashi M; Tsutsui T; Ohnishi M; Fujii M; Matsumoto T; Yamamoto T; Takayama T; Kinoshita M
    J Card Fail; 2001 Dec; 7(4):322-8. PubMed ID: 11782855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble Fas gene therapy protects against Fas-mediated apoptosis of hepatocytes but not the lethal effects of Fas-induced TNF-alpha production by Kupffer cells.
    Matsuki Y; Li L; Hsu HC; Yang PA; Zheng R; Edwards CK; Chaudry IH; Zhang HG; Mountz JD
    Cell Death Differ; 2002 Jun; 9(6):626-35. PubMed ID: 12032671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VEINCTR-N, an immunogenic epitope of Fas (CD95/Apo-I), and soluble Fas enhance T-cell apoptosis in vitro. II. Functional analysis and possible implications in HIV-1 disease.
    Silvestris F; Cafforio P; Tucci M; Del Prete A; Dammacco F
    Mol Med; 2000 Jun; 6(6):509-26. PubMed ID: 10972087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble Fas is a marker of peripheral arterial occlusive disease in haemodialysis patients.
    Masse M; Hébert MJ; Troyanov S; Vigneault N; Sirois I; Madore F
    Nephrol Dial Transplant; 2002 Mar; 17(3):485-91. PubMed ID: 11865097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Escape from cardiomyocyte apoptosis by enterovirus persistence due to elevated soluble Fas-receptors.
    Alter P; Maisch B
    Z Kardiol; 2004 Jul; 93(7):524-32. PubMed ID: 15243763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma content of soluble fas antigen in patients with adrenal tumors and tumor-like pathologies.
    Kushlinskii NE; Britvin TA; Polyakova GA; Abbasova SG; Baronini AA; Tishenina RS; Molchanova GS; Sel'chuk VY; Pirogov DA; Bogatyrev OP; Lipkin VM; Kalinin AP
    Bull Exp Biol Med; 2002 Aug; 134(2):171-4. PubMed ID: 12459844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.